Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SHR-2017 Injection in Postmenopausal Women

Inclusion Criteria: 1. Postmenopausal women ages ≥ 50 years. 2. Body weight≥45 kg, body mass index (BMI) of 18.0 to 29.0 kg/m2 (inclusive). 3. Understand in detail the content, procedure and possible adverse effects of the trial, and voluntarily sign the written informed consent form (ICF). Exclusion Criteria: 1. History of malignancy. 2. Menopause due to simple hysterectomy. 3. Subjects with poor blood pressure control. 4. Subjects with positive tests for infectious diseases. 5. Have a history of diseases related to bone metabolism. 6. Use of drugs that may affect bone metabolism before administration. 7. Have a history of alcoholism, medical abuse, or drug use, or have a positive alcohol breath test or drug abuse screening. 8. Female who are pregnant or breastfeeding. 9. Unable to tolerate venipunctures or have a history of fainting needles and blood. 10. Other reasons that the investigator consider it inappropriate to participate in the trial.